Italia markets open in 8 hours 15 minutes
Dow Jones
38.807,33 +96,04 (+0,25%) Nasdaq
17.187,90 +330,86 (+1,96%) Nikkei 225
38.490,17 -347,29 (-0,89%) EUR/USD
1,0875 -0,0007 (-0,07%) Bitcoin EUR
65.457,65 +536,77 (+0,83%) CMC Crypto 200
1.522,68 +48,93 (+3,32%)
Eliem Therapeutics, Inc. (ELYM)
NasdaqGM - NasdaqGM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 04:00PM EDT
Dopo ore:
| Chiusura precedente | 8,23 |
| Aperto | 8,50 |
| Denaro | 8,65 x 100 |
| Domanda | 8,91 x 100 |
| Min-Max giorno | 8,34 - 9,58 |
| Intervallo di 52 settimane | 2,34 - 11,55 |
| Volume | |
| Media Volume | 883.947 |
| Capitalizzazione | 254,485M |
| Beta (mensile su 5 anni) | -0,35 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,52 |
| Prossima data utili | N/D |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireEliem Therapeutics Announces Plans to Explore Strategic Alternatives
SEATTLE and CAMBRIDGE, United Kingdom, July 20, 2023 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM) today announced that it has completed a review of its business, including the status of its programs, resources, and capabilities, and has made the determination to halt further development of its Kv7 program and to conduct a comprehensive exploration of strategic alternatives focused on maximizing shareholder value. Eliem has engaged Leerink Partners to act as a strategic advisor in
© 2024 Yahoo. Tutti i diritti riservati.